Gordon Murdo 4
4 · AMGEN INC · Filed Nov 13, 2025
Insider Transaction Report
Form 4
AMGEN INCAMGN
Gordon Murdo
EVP, Global Commercial Ops
Transactions
- Sale
Common Stock
2025-11-12$336.83/sh−6,879$2,317,071→ 41,923 total
Footnotes (2)
- [F1]The price reported is an average price. The prices ranged from $336.7301 to $337.0500 per share. Full information regarding the number of shares purchased at each separate price within the range is available upon request by the SEC staff, the issuer or a security holder of the issuer.
- [F2]These shares include 647 Dividend Equivalents (DEs) granted pursuant to the Amgen Inc. Second Amended and Restated 2009 Equity Incentive Plan and subject to a qualifying dividend reinvestment plan. DEs are credited to the reporting person's unvested RSUs and are paid out in shares of the Company's common stock on a one-to-one basis according to the vesting schedule, along with a cash payment for any remaining fractional share amount.